Transaction #18112 · Form 4 · 0001753159-25-000006
Guardant Health, Inc. · Other acquisition · Common Stock
Guardant Health, Inc. · Transacted December 8, 2025 · Filed December 10, 2025
What does this filing report?
An SEC Form 4 filing for Guardant Health, Inc. records an other acquisition involving Common Stock on December 8, 2025. The reported quantity was 193,973. The filing date is December 10, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Guardant Health, Inc.
- Company CIK
- 0001576280
- Security type
- Non-derivative
- Acquisition type
- Other acquisition · Code J
- Quantity acquired
- 193,973
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 218,223
- Ownership description
- Shares held by Maryam Eskandari 2018 Children's Remainder Trust, Dated 9/25/2018
- SEC acceptance time
- Dec 10, 2025, 9:33 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Talasaz AmirAli ↗
Co-Chief Executive Officer · Director
CIK 0001753159
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Reflects changes in form of ownership from Talasaz Investments LP due to the transfer of shares to The AmirAli Talasaz 2018 Children's Remainder Trust dated 9/25/2018, and Maryam Eskandari 2018 Children's Remainder Trust, dated 9/25/2018.
- F2
- Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.00 to $104.75. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3
- Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.81. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.